Medicare's proposed dialysis cut takes a toll on device makers
Medical device makers DaVita and Fresenius suffer Wall Street losses amid Medicare's proposal to cut about 9% from dialysis reimbursements.
Dialysis technology makers slid hard today after the Center for Medicare & Medicaid Services proposed a reimbursement decrease of more than 9% for 2014.
The cuts, part of a new federal budget agreement designed in part to stem over-spending on certain drugs, also proposed a 9.4% cut to reimbursements for dialysis. The budget proposal will undergo a period of public comment and review before it's slated to take effect.